Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 85872453 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY
• Document 86299032 overview

---

---

The "ONCOZENE" trademark, serial number 85872453 , was filed on 11th of March 2013 with a mark drawing code of 4000 and its transaction date is 85872453. The attorney assigned is Scott D. Woldow, attorney docket number 045331.836 (. Since 7th of April 2014, the document can be found in the L30 law office in the publication and issue section. The employee responsible is GRIFFIN, JAMES and the date it was published for opposition on 11/26/2013. The status of the trademark was checked last on 01/21/2014.

Prior registrations: 2877125 , 3818708

The corresponded responsible for this trademark is Scott D. Woldow, located at SMITH, GAMBRELL & RUSSELL, LLP, Suite 400, 1055 Thomas Jefferson St., NW.

The state or country where the trademark was organized is TX by Celonova Biosciences, Inc.. The legal entity type behing it is a Corporation, located at 18615 Tuscany Stone, Suite 100, San Antonio, TX zip 78258.Other trademarks by this applicant: COBRA PZF, VETERINOVA ANIMAL BIOSCIENCES, DEFENSE FOR MEDICAL IMPLANTS.

GOODS AND/OR SERVICES
International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
U.S. Class	044 - Dental, Medical, and Surgical Appliances
Class Status	6 - Active
Status Date	03/14/2013
Primary Code	010
Goods codes
GS0101	Medical products, namely, embolic microspheres for use in endovascular therapy, for treatment of hypervascularized tumors and to control and prevent abnormal bleeding; Medical products, namely, embolic microspheres for embolization in the form of particles; Medical products, namely, embolic microspheres in the form of particles to slow or block blood flow for mediating devascularizations; Medical products, namely, embolic microspheres in the form of particles to block blood flow throughout the vasculature system; Medical products, namely, embolic microspheres in the form of particles to treat hemorrhages, arteriovenous malformations, hemangioendothelioma, cerebral aneurysms, muscle hypertrophy, hypertrophic cardiomyopathy, gastrointestinal bleeding, trauma, epistaxis, bone cysts, bone metastases, vertebral metastases, varicoceles, congenital hemangioma, artiovenous fistulae, vena cava, vascular anomalies, priapism, prostatic hematuria, hemoptysis, hemorrhagic cystitis, and post-partum hemorrhage; Medical products, namely, embolic microspheres in the form of particles to prevent or reduce blood flow through any tissue or organ of interest in order to reduce the growths of hypervascular tissues or malignant cells, tumors, lesions, hepatocellular carcinoma, and fibroids; Medical products, namely, embolic microspheres in the form of particles to treat vascular conditions; Medical products, namely, embolic microspheres in the form of embolic particle implants; Medical products, namely, embolic microspheres for treating vascular anomalies of the body

PROSECUTION HISTORY
Date	Description	Type	Code
04/07/2014	CASE ASSIGNED TO INTENT TO USE PARALEGAL	A - Allowance for Publication	AITU
03/13/2014	TEAS STATEMENT OF USE RECEIVED	I - Incoming Correspondence	EISU - TEAS STATEMENT OF USE RECEIVED
01/21/2014	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	E	NOAM
11/26/2013	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	E	NPUB - NOTICE OF PUBLICATION
11/26/2013	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
11/06/2013	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED	E	NONP
10/21/2013	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
10/18/2013	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2013	TEAS/EMAIL CORRESPONDENCE ENTERED	I - Incoming Correspondence	TEME - TEAS/EMAIL CORRESPONDENCE ENTERED
10/02/2013	CORRESPONDENCE RECEIVED IN LAW OFFICE	I - Incoming Correspondence	CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE
10/02/2013	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
10/01/2013	TEAS RESPONSE TO OFFICE ACTION RECEIVED	I - Incoming Correspondence	TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2013	NOTIFICATION OF NON-FINAL ACTION E-MAILED	O - Outgoing Correspondence	GNRN
06/21/2013	NON-FINAL ACTION E-MAILED	F - First Action	GNRT - NON-FINAL ACTION E-MAILED
06/21/2013	NON-FINAL ACTION WRITTEN	R - Renewal	CNRT - NON-FINAL ACTION WRITTEN
06/20/2013	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
05/30/2013	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/14/2013	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
03/14/2013	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.